Notice of final decision to amend (or not amend) the current Poisons Standard - June 2022 ACMS #38 - Psilocybine and MDMA
Published
This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZS, this notice publishes the:
- decisions made by a delegate of the Secretary pursuant to regulation 42ZCZR;
- reasons for those final decisions; and
- date of effect of the decisions,
relating to psilocybine (psilocybin) and MDMA.
Final decisions and reasons
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- 1 Notice of final decisions to amend (or not amend) the current Poisons Standard
- 2 Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #38, June 2022)
- 2.1 Final decisions in relation to psilocybine and MDMA